CD8A and acute myeloid leukemia: In a murine model of AML, CD8+ T cells were shown to present a typical exhaustion phenotype (TIM-3/PD-1-positive), whereby the expression of TIM-3/PD-1 increases during AML progression and can be partially reduced by anti-PD1 treatment [12].